Dandelion (Taraxacum officinale and Taraxacum mongolicum), a perennial plant long dismissed as a common weed, has emerged as a subject of serious scientific investigation for its diverse bioactive properties. Used for centuries in traditional medicine systems across Europe, Asia, and North America to support liver function, digestion, and general wellness, dandelion is now being examined through modern research as a source of potentially therapeutic phytochemicals. The plant contains an array of bioactive compounds including polyphenols, flavonoids such as luteolin and quercetin, sesquiterpene lactones, triterpenes, and various phenolic acids. These constituents contribute to antioxidant, anti-inflammatory, and metabolic regulatory effects observed in laboratory and animal studies, positioning dandelion root extract as a candidate for further investigation in conditions ranging from cancer to metabolic disorders and neurological damage. However, it is critical to emphasize that the evidence base remains almost entirely preclinical: compelling findings in cell culture and animal models have not yet been validated in controlled human trials, and dandelion should not be considered an established treatment, cure, or substitute for evidence-based medical care.
Where are your Clinical Trials?
It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized.
0 Comments